Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoi

Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoi

Item

http://www.wikidata.org/entity/Q36822149

Q36822149

about

Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.Current and future biomarkers for pancreatic adenocarcinoma.Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer.Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the "precision medicine" of pancreatic cancer: A retrospective study.Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression

P2860

Q36342657-CB04CFB6-78C2-4A8D-8187-2A8E63F7EBF1 Q38670577-96ED559C-9F95-4272-AC62-1B3FC19B3415 Q49576059-00E236DB-A98A-4850-BEB3-31329EB49DFF Q52671460-879DB349-6A05-42E0-8751-A5D3EB419157 Q55429215-3E0B131C-8143-410B-A5EF-4092F9548ED1 Q58694311-12819632-2074-42A0-94BB-6892D2FB364D

P2860

Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoi

Item

http://www.wikidata.org/entity/Q36822149

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Human Equilibrative Nucleoside ...... Ductal Adenocarcinoma Undergoi

@en

type

Item

label

Human Equilibrative Nucleoside ...... Ductal Adenocarcinoma Undergoi

@en

prefLabel

Human Equilibrative Nucleoside ...... Ductal Adenocarcinoma Undergoi

@en

P1476

Human Equilibrative Nucleoside ...... Ductal Adenocarcinoma Undergoi

@en

P2093

Hiroyuki Inoue

http://www.w3.org/2001/XMLSchema#string

Junya Tsuboi

http://www.w3.org/2001/XMLSchema#string

Katsunori Uchida

http://www.w3.org/2001/XMLSchema#string

Kazuki Kanayama

http://www.w3.org/2001/XMLSchema#string

Kyosuke Tanaka

http://www.w3.org/2001/XMLSchema#string

Masanobu Usui

http://www.w3.org/2001/XMLSchema#string

Masashi Kishiwada

http://www.w3.org/2001/XMLSchema#string

Misao Yoneda

http://www.w3.org/2001/XMLSchema#string

Naohisa Kuriyama

http://www.w3.org/2001/XMLSchema#string

Naoyuki Katayama

http://www.w3.org/2001/XMLSchema#string

P2860

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosi

Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expr

Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future.

Nucleoside transport and its significance for anticancer drug resistance.

Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer

Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer.

P304

761-771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPA.0000000000000597

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291328504

http://www.w3.org/2001/XMLSchema#string

P698

26784908

http://www.w3.org/2001/XMLSchema#string

P932

4839740

http://www.w3.org/2001/XMLSchema#string

Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoi

about

P2860

P2860

Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoi

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932